[HTML][HTML] CD39–A bright target for cancer immunotherapy
S Guo, F Han, W Zhu - Biomedicine & Pharmacotherapy, 2022 - Elsevier
The ATP-adenosine pathway functions as a key modulator of innate and adaptive immunity
within the tumor microenvironment, and cancer immune evasion largely involves the …
within the tumor microenvironment, and cancer immune evasion largely involves the …
Unraveling the Intricacies of CD73/Adenosine Signaling: The Pulmonary Immune and Stromal Microenvironment in Lung Cancer
Simple Summary CD73 and adenosine are garnering significant attention in lung cancer
research. CD73, an enzyme crucial for adenosine production, is found in various cells …
research. CD73, an enzyme crucial for adenosine production, is found in various cells …
Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma
Background Advances in tumor immunotherapy have been developed for patients with
advanced recurrent or metastatic (R/M) HNSCC. However, the response of most HNSCC …
advanced recurrent or metastatic (R/M) HNSCC. However, the response of most HNSCC …
Tumor-induced T cell polarization by Schwann cells
Nerve-cancer crosstalk resulting in either tumor neurogenesis or intratumoral
neurodegeneration is critically controlled by Schwann cells, the principal glial cells of the …
neurodegeneration is critically controlled by Schwann cells, the principal glial cells of the …
High dimensional immune profiling of smoldering multiple myeloma distinguishes distinct tumor microenvironments
N Fernandez, D Perumal, A Rahman… - … Myeloma and Leukemia, 2022 - Elsevier
Background Multiple myeloma (MM) is a malignancy of plasma cells that arises from
premalignant Monoclonal Gammopathy of Undetermined Significance (MGUS) and often …
premalignant Monoclonal Gammopathy of Undetermined Significance (MGUS) and often …
Single-cell phenotyping of CD73 expression reveals the diversity of the tumor immune microenvironment and reflects the prognosis of bladder cancer
M Izawa, N Tanaka, T Murakami, T Anno… - Laboratory …, 2023 - Elsevier
The cutting edge of cancer immunotherapy extends to ecto-5′-nucleotidase (CD73), a cell
membrane enzyme that targets the metabolism of extracellular adenosine. We herein …
membrane enzyme that targets the metabolism of extracellular adenosine. We herein …
1042 The dual function of the adenosine pathway in the liposarcoma tumor microenvironment
J Oliva, Y Lee, R Rodriguez, K Tomczak, D Ingram… - 2022 - jitc.bmj.com
Background Single agent anti-PD1 therapy has shown limited clinical benefit in
liposarcoma, but combination with anti-CTLA-4 demonstrated a higher response rate. 1-3 In …
liposarcoma, but combination with anti-CTLA-4 demonstrated a higher response rate. 1-3 In …
Half a century of immunological discovery: EJI celebrates its golden anniversary!
JD Santo, N Bakocevic - European Journal of Immunology, 2021 - search.ebscohost.com
Clinical and translation immunology research in EJI continues to grow (about a quarter of
our published content in 2020), and are among EJI's top read articles. GRAPH Dear readers …
our published content in 2020), and are among EJI's top read articles. GRAPH Dear readers …
RNA Sequencing to Explore Dominant Isoform Switch During CCR6+ Memory T Cell Activation
S Zhao, A Barron, K Dower - 2021 - researchsquare.com
Alternative splicing (AS) is an essential, but under-investigated component of T-cell function
during immune responses. Recent developments in RNA sequencing (RNA-seq) …
during immune responses. Recent developments in RNA sequencing (RNA-seq) …